Skip to content

xTAG® RVP (Respiratory Viral Panel) I019C0111Recalls & reported problems

Luminex Molecular Diagnostics, Inc · The xTAG® Respiratory Viral Panel (RVP) is a qualitative nucleic acid multiplex test intended for the simultaneous detection and identification of multiple respiratory virus nucleic acids in nasopharyngeal swabs from individuals suspected of respiratory tract infections. · Class 1

Data updated Oct 18, 2026 from official FDA records · Editorial policy

1 open recall names this device. See the recall details and contact the manufacturer or your healthcare provider.

Adverse event reports
0
Deaths reported
0
Injuries reported
0
Recalls naming it
1

Summary

No MAUDE adverse event reports in our data reference this device identifier directly.

1 FDA recall record name this device's identifier, 1 still open.

Reports come from manufacturers, hospitals and patients and are not verified by the FDA. A report does not prove the device caused the event, and counts can't be used to compare devices or estimate failure rates. What reports can and can't tell you · How this data works · Data updated Oct 18, 2026.

Recalls naming this device

  1. Jul 16, 2019Class IIOpen, Classified

    The Assay may give a false negative result when detecting and subtyping Influenza A (H3) and detecting RSV A in patient specimens. However, the assay will continue to detect Influenza A, Influenza B, RSV B and all other targets in accordance with each of these products performance claims.

    Z-0161-2020 · Root cause: Device Design · Recall details · FDA record ↗

Other CLINICAL SAMPLE CONCENTRATOR devices

All CLINICAL SAMPLE CONCENTRATOR devices →

Sources and updates

How reports and recalls are matched · Editorial policy · Report an error on this page